期刊文献+

紫杉醇联合顺铂5-FU治疗原发灶不明恶性肿瘤一例分析

下载PDF
导出
摘要 原发灶不明恶性肿瘤(unknown primary tumor,UPT)是一种异源性发生的,首先表现为转移性病灶、确诊时找不到原发灶的一类恶性肿瘤,既往称之为原发灶不明的转移癌、来源不明的转移癌(MUO)、隐匿性癌等。其发病率约占实体瘤的2.3%~42%,文献E33报道,UPT的中位生存时间仅为4.8个月。本科近年收治1例UPT伴全身多发转移患者,报告如下。
出处 《山西医药杂志(上半月)》 CAS 2013年第4期459-461,共3页 Shanxi Medical Journal
  • 相关文献

参考文献13

  • 1Mevio E, Gorini E, Sbrocca M, et al. The role of positron e- mission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary turnout. Acta Otorhinolaryngol Ital, 2004, 24(6): 342-347.
  • 2Pavlidis N,Fizazi K. Cancer of unknown primary(CUP). Crit Rev Oncol Heraatol, 2005,54 (3) : 243-250.
  • 3王成锋,田艳涛,张建伟.不明原发灶肿瘤1273例报告[J].中国微创外科杂志,2007,7(11):1072-1074. 被引量:5
  • 4Van de Wouw AJ ,Janssen-Heijnen ML, Coebergh JW, et al. Epidemiology of unknown primary tumours: incidence and population-based survival of 1285 patients in Southeast Neth- erlands,1984-1992. Eur J Cancer,2002,38(3) :409-413.
  • 5Shaw PHS,Adams R,Jordan C,et al. A clinical review of the investigation and management of carcinoma of unknown pri- mary in asingle cancer network. Clin Oncol, 2007,19 ( 1 ) : 87- 95.
  • 6Vant-Veer LJ,Weigelt B. Road map to metastasis. Nat Med, 2003,9 (8) : 999-1000.
  • 7Bugat R, Bataillard A, Lesimple T, et al. Summary of the standards,options and recommendations for the management of patients with carcinoma of unknown primary site. Br J Cancer, 2003,89 Suppl 1 : $59-$66.
  • 8Greco FA, Burris HA, Erland EB, et al. Carcinoma of un- known primary site. Long term follow-up after treatment with paclitaxe| earboplatin and etoposide. Cancer, 2000, 89 26552660.
  • 9和钢,李锦.原发灶不明转移瘤的临床诊治与转归[J].现代实用医学,2002,14(9):479-480. 被引量:3
  • 10Park YH,Ryoo BY,Choi SJ, et al. A Phase II study of paeli- taxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Jpn J Clin 0n- col,2004,34(11) :681-685.

二级参考文献37

  • 1陈华,黄建瑾.原发灶不明癌24例临床分析[J].中国实用医药,2007,2(36):39-41. 被引量:5
  • 2吴毅.原发灶不明颈部转移性鳞癌的诊治[J].中华肿瘤防治杂志,2006,13(12):881-883. 被引量:9
  • 3[1]Greco FA, Hainsworth JD. Tumors of unknown origin[J]. CA,1992,42:96.
  • 4[2]Sporn JR,Greenberg BR. Empirical chemotherapy for adenocarcinoma of unknown primary tumor site[J]. Semin Oncol,1993,20:261.
  • 5[3]Treat J, Falchuk SG, Tremblay C, et al. PhaseⅡtrial of methotrexate-FAM in adenocarcinoma of unknown primary[J]. Eur J Cancer Clin Oncol,1989,25:1053.
  • 6[4]Hainsworth JD,Wright EP,Gray GF Jr,et al. Poorly differentiated carcinoma of unknown primary site:correlation of light microscopic findings with response to cisplatin-based combination chemotherapy[J]. J Clin Oncol, 1987,5:1272.
  • 7[5]Weir L,Keane T,Cummings B,et al. Radiation treatment of cervical lymph node metastasis from an unknown primary:an analysis of outcome by treatment volume and other prognostic factors[J].Radiother Oncol,1995,35:206.
  • 8[6]Carlson LS,Fletcher GH,Oswald MJ. Guidelines for the radiotherapeutic techniques for cervical metastases from an unknown primary[J]. Int J Radiat Oncol Biol Phys,1986,12:2101.
  • 9[1]Abbruzzese JL,Abbruzzese MC,Lenzi R,et al.Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.J Clin Oncol,1995,13(8):2094 -2103.
  • 10[2]Pavlidis N,Fizazi K.Cancer of unknown primary (CUP).Crit Rev Oncol Hematol,2005,54(3):243-250.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部